T1	Outcomes 0 21	Histologic conversion
T2	Outcomes 698 725	complete response rate (CR)
T3	Outcomes 754 767	achieved a CR
T4	Outcomes 779 788	relapsed.
T5	Outcomes 833 845	achieve a CR
T6	Outcomes 849 862	achieved a CR
T7	Outcomes 873 882	relapsed.
T8	Outcomes 883 904	Histologic conversion
T9	Outcomes 1044 1073	actuarial risk for conversion
T10	Outcomes 1092 1099	greater
T11	Outcomes 1119 1161	median time to documentation of conversion
T12	Outcomes 1177 1188	most common
T13	Outcomes 1197 1218	histologic conversion
T14	Outcomes 1244 1265	histiocytic lymphoma.
T15	Outcomes 1277 1298	histologic conversion
T16	Outcomes 1332 1360	aggressive clinical behavior
T17	Outcomes 1386 1401	median survival
T18	Outcomes 1408 1418	conversion
T19	Outcomes 1467 1480	achieved a CR
T20	Outcomes 1487 1497	conversion
T21	Outcomes 1509 1546	favorable outcome (actuarial survival
T22	Outcomes 1573 1585	risk factors
T23	Outcomes 1600 1621	histologic conversion
